BACKGROUND AND PURPOSE: We investigated whether brain arteriovenous malformation silent intralesional microhemorrhage, that is, asymptomatic bleeding in the nidal compartment, might serve as a marker for increased risk of symptomatic intracranial hemorrhage (ICH). We evaluated 2 markers to assess the occurrence of silent intralesional microhemorrhage: neuroradiological assessment of evidence of old hemorrhage-imaging evidence of bleeding before the outcome events-and hemosiderin positivity in hematoxylin and eosin-stained paraffin block sections. METHODS: We identified cases from our brain arteriovenous malformation database with recorded neuroradiological data or available surgical paraffin blocks. Using 2 end points, index ICH or new ICH after diagnosis (censored at treatment, loss to follow-up, or death), we performed logistic or Cox regression to assess evidence of old hemorrhage and hemosiderin positivity adjusting for age, sex, deep-only venous drainage, maximal brain arteriovenous malformation size, deep location, and associated arterial aneurysms. RESULTS: Evidence of old hemorrhage was present in 6.5% (n=975) of patients and highly predictive of index ICH (P<0.001; OR, 3.97; 95% CI, 2.1-7.5) adjusting for other risk factors. In a multivariable model (n=643), evidence of old hemorrhage was an independent predictor of new ICH (hazard ratio, 3.53; 95% CI, 1.35-9.23; P=0.010). Hemosiderin positivity was found in 36.2% (29.6% in unruptured; 47.8% in ruptured; P=0.04) and associated with index ICH in univariate (OR, 2.18; 95% CI, 1.03-4.61; P=0.042; n=127) and multivariable models (OR, 3.64; 95% CI, 1.11-12.00; P=0.034; n=79). CONCLUSIONS: The prevalence of silent intralesional microhemorrhage is high and there is evidence for an association with both index and subsequent ICH. Further development of means to detect silent intralesional microhemorrhage during brain arteriovenous malformation evaluation may present an opportunity to improve risk stratification, especially for unruptured brain arteriovenous malformations.
BACKGROUND AND PURPOSE: We investigated whether brain arteriovenous malformation silent intralesional microhemorrhage, that is, asymptomatic bleeding in the nidal compartment, might serve as a marker for increased risk of symptomatic intracranial hemorrhage (ICH). We evaluated 2 markers to assess the occurrence of silent intralesional microhemorrhage: neuroradiological assessment of evidence of old hemorrhage-imaging evidence of bleeding before the outcome events-and hemosiderin positivity in hematoxylin and eosin-stained paraffin block sections. METHODS: We identified cases from our brain arteriovenous malformation database with recorded neuroradiological data or available surgical paraffin blocks. Using 2 end points, index ICH or new ICH after diagnosis (censored at treatment, loss to follow-up, or death), we performed logistic or Cox regression to assess evidence of old hemorrhage and hemosiderin positivity adjusting for age, sex, deep-only venous drainage, maximal brain arteriovenous malformation size, deep location, and associated arterial aneurysms. RESULTS: Evidence of old hemorrhage was present in 6.5% (n=975) of patients and highly predictive of index ICH (P<0.001; OR, 3.97; 95% CI, 2.1-7.5) adjusting for other risk factors. In a multivariable model (n=643), evidence of old hemorrhage was an independent predictor of new ICH (hazard ratio, 3.53; 95% CI, 1.35-9.23; P=0.010). Hemosiderin positivity was found in 36.2% (29.6% in unruptured; 47.8% in ruptured; P=0.04) and associated with index ICH in univariate (OR, 2.18; 95% CI, 1.03-4.61; P=0.042; n=127) and multivariable models (OR, 3.64; 95% CI, 1.11-12.00; P=0.034; n=79). CONCLUSIONS: The prevalence of silent intralesional microhemorrhage is high and there is evidence for an association with both index and subsequent ICH. Further development of means to detect silent intralesional microhemorrhage during brain arteriovenous malformation evaluation may present an opportunity to improve risk stratification, especially for unruptured brain arteriovenous malformations.
Authors: R P Atkinson; I A Awad; H H Batjer; C F Dowd; A Furlan; S L Giannotta; C R Gomez; D Gress; G Hademenos; V Halbach; J C Hemphill; R T Higashida; L N Hopkins; M B Horowitz; S C Johnston; M W Lawton; M W McDermott; A M Malek; J P Mohr; A I Qureshi; H Riina; W S Smith; J Pile-Spellman; R F Spetzler; T A Tomsick; W L Young Journal: Stroke Date: 2001-06 Impact factor: 7.914
Authors: Helen Kim; Stephen Sidney; Charles E McCulloch; K Y Trudy Poon; Vineeta Singh; S Claiborne Johnston; Nerissa U Ko; Achal S Achrol; Michael T Lawton; Randall T Higashida; William L Young Journal: Stroke Date: 2007-08-02 Impact factor: 7.914
Authors: C Stapf; H Mast; R R Sciacca; J H Choi; A V Khaw; E S Connolly; J Pile-Spellman; J P Mohr Journal: Neurology Date: 2006-05-09 Impact factor: 9.910
Authors: Yongmei Chen; Wei Zhu; Andrew W Bollen; Michael T Lawton; Nicholas M Barbaro; Christopher F Dowd; Tomoki Hashimoto; Guo-Yuan Yang; William L Young Journal: Neurosurgery Date: 2008-06 Impact factor: 4.654
Authors: Matthew Schrag; Grant McAuley; Justine Pomakian; Arshad Jiffry; Spencer Tung; Claudius Mueller; Harry V Vinters; E Mark Haacke; Barbara Holshouser; Daniel Kido; Wolff M Kirsch Journal: Acta Neuropathol Date: 2010-03 Impact factor: 17.088
Authors: L Prayer; D Wimberger; R Stiglbauer; J Kramer; B Richling; G Bavinzski; T Czech; H Imhof Journal: Neuroradiology Date: 1993 Impact factor: 2.804
Authors: Steven M Greenberg; Meike W Vernooij; Charlotte Cordonnier; Anand Viswanathan; Rustam Al-Shahi Salman; Steven Warach; Lenore J Launer; Mark A Van Buchem; Monique Mb Breteler Journal: Lancet Neurol Date: 2009-02 Impact factor: 44.182
Authors: Chun-Xue Wu; Li Ma; Xu-Zhu Chen; Xiao-Lin Chen; Yu Chen; Yuan-Li Zhao; Christopher Hess; Helen Kim; Heng-Wei Jin; Jun Ma Journal: World Neurosurg Date: 2018-05-30 Impact factor: 2.104
Authors: Yi Guo; Tarik Tihan; Helen Kim; Christopher Hess; Michael T Lawton; William L Young; Yuanli Zhao; Hua Su Journal: Neuroimmunol Neuroinflamm Date: 2014
Authors: Rui Zhang; Zhenying Han; Vincent Degos; Fanxia Shen; Eun-Jung Choi; Zhengda Sun; Shuai Kang; Michael Wong; Wan Zhu; Lei Zhan; Helen M Arthur; S Paul Oh; Marie E Faughnan; Hua Su Journal: Angiogenesis Date: 2016-06-20 Impact factor: 9.596
Authors: Wanqiu Chen; Yi Guo; Espen J Walker; Fanxia Shen; Kristine Jun; S Paul Oh; Vincent Degos; Michael T Lawton; Tarik Tihan; Dimitrios Davalos; Katerina Akassoglou; Jeffrey Nelson; John Pile-Spellman; Hua Su; William L Young Journal: Arterioscler Thromb Vasc Biol Date: 2012-12-13 Impact factor: 8.311
Authors: Xiaolin Chen; Daniel L Cooke; David Saloner; Jeffrey Nelson; Hua Su; Michael T Lawton; Christopher Hess; Tarik Tihan; Yuanli Zhao; Helen Kim Journal: Stroke Date: 2017-08-30 Impact factor: 7.914